logo

For the Inventor, By the Inventor

East Northport, NY, United States of America

Arno G Steinig

This inventor holds 15 USPTO granted patents and 3 published patent applications and 5 EPO patents, primarily in Kinase Inhibitors. Top assignee: Osi Pharmaceuticals, Inc.. Active years: 2005-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arno G Steinig. Retrieved from https://idiyas.com/inventor/arno-g-steinig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 40.0

 

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 69(Granted Patents)


Location History:

  • Farmingdale, NY (US) (2009)
  • East Northport, NY (US) (2005 - 2013)
  • E. Northport, NY (US) (2010 - 2014)
  • Carmel, NY (US) (2016)

Company Filing History:

goldMedal15 out of 118 
 
Osi Pharmaceuticals, Inc.
 patents

Years Active: 2005-2016

Loading Chart...
Loading Chart...
Areas of Expertise:
Cancer Treatment
Protein Kinase Inhibitors
Pyrrolo Compounds
Bicyclic Substitutions
Fused Bicyclic Compounds
Aminofuropyridine Derivatives
Thienol Pyrimidines
Imidazopyrazine
Pyrimidine Antagonists
Selective Antagonists
Heterobicyclic Structures
Synthesis Techniques
15 patents (USPTO):Explore Patents
1. 9351974 - Substituted pteridinones for the treatment of cancer (2016-05-31),
2. 8735405 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors (2014-05-27),
3. 8653268 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors (2014-02-18),
4. 8592448 - Substituted pyrrolo[2,3-b]-pyridines and -pyrazines (2013-11-26),
5. 8445510 - Fused bicyclic kinase inhibitors (2013-05-21),
6. 8378104 - 7-aminofuropyridine derivatives (2013-02-19),
7. 8367826 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors (2013-02-05),
8. 8178668 - 2-aminopyridine kinase inhibitors (2012-05-15),
9. 8022206 - Furo[3,2-C]pyridines (2011-09-20),
10. 7820662 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors (2010-10-26),
11. 7645754 - [object Object] (2010-01-12),
12. 7566721 - Substituted thienol[2,3-d]pyrimidines as kinase inhibitors (2009-07-28),
13. 7501407 - [object Object] (2009-03-10),
14. 7459554 - Imidazopyrazine tyrosine kinase inhibitors (2008-12-02),
15. 6916804 - Pyrimidine A2b selective antagonist compounds, their synthesis and use (2005-07-12),

Title: Arno G. Steinig: Innovator in Cancer Treatment

Introduction

Arno G. Steinig is a prominent inventor based in East Northport, NY (US), known for his significant contributions to the field of cancer treatment. With a total of 15 patents to his name, he has made remarkable strides in developing innovative compounds aimed at combating various forms of cancer.

Latest Patents

Among his latest patents, Steinig has developed substituted pteridinones for the treatment of cancer. These compounds, defined by specific formulas, include pharmaceutically acceptable salts, synthesis methods, intermediates, formulations, and treatment methods for diseases, particularly cancers driven or mediated by RSK. Another notable patent involves 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors, showcasing his commitment to advancing cancer therapies.

Career Highlights

Steinig's career is marked by his work at Osi Pharmaceuticals, Inc., where he has played a crucial role in research and development. His innovative approach and dedication to improving cancer treatment options have positioned him as a key figure in the pharmaceutical industry.

Collaborations

Throughout his career, Steinig has collaborated with esteemed colleagues, including Mark Joseph Mulvihill and An-Hu Li. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking treatments.

Conclusion

Arno G. Steinig's contributions to cancer treatment through his patents and collaborations highlight his importance in the field of pharmaceuticals. His innovative work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…